Indaptus Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
INDP on Nasdaq
Industry
Pharmaceutical Preparations
Location
3 Columbus Circle, 15 Th Floor, New York, New York

There are no Buy or Sell transactions made by insiders since 9/9/2023

Indaptus Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Glen R. Anderson 10%+ Owner $2.79M Aug 10, 2023
Hoonmo Lee Director $1.63M Aug 4, 2021
Jeffrey Meckler CEO and Director, Director $448K Aug 8, 2024
Boyan Litchev Chief Medical Officer $2.69K Feb 1, 2022
Hila Karah Director Jun 6, 2024
Walt Linscott Chief Operating Officer Jan 22, 2024
Michael Newman CSO and Director, Director, 10%+ Owner Jan 22, 2024
Mark J. Gilbert Director Jun 6, 2024
William B. Hayes Director Jun 6, 2024
Brian O'callaghan Director Sep 30, 2022
Roger Pomerantz Director Jun 6, 2024
Roger J. Waltzman Chief Medical Officer Jan 22, 2024
Robert Martell Director Jun 6, 2024
Nir Sassi Chief Financial Officer Jan 22, 2024
Anthony Maddaluna Director Jun 6, 2024

Recent Insider Transactions by Companies or Individuals for Indaptus Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.